Arbs has 4 known drug interactions based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Aliskiren, Sacubitril And Valsartan, Sumatriptan Succinate And Naproxen Sodium. Patients taking Arbs should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 4
- Contraindicated
- 1
- Major
- 2
- Moderate
- 1
Contraindicated (1)
- Arbs + Aliskiren— Concomitant use of aliskiren with ARBs in diabetic patients is contraindicated. In non-diabetics, avoid combined use par…
Major (2)
- Arbs + Sacubitril And Valsartan— Avoid use as sacubitril and valsartan already contains the angiotensin II receptor blocker valsartan.
- Arbs + Sumatriptan Succinate And Naproxen Sodium— Concomitant use in elderly, volume depleted, or renally impaired patients may result in renal function deterioration. Mo…
Moderate (1)
- Arbs + Meloxicam, Rizatriptan— Meloxicam may diminish antihypertensive effect and in elderly/volume-depleted/renal impairment patients may result in re…